BRONCHIECTASIS may silently increase risk of non-tuberculous mycobacteria infection, according to new genetic evidence.

A computational study shows for the first time how different parts of the human airway experience levels of pressure and ...

A new fund for families affected by a deadly lung disease has been launched in honour of a young Whangārei woman who was a ...

Adults aged over 65 with chronic respiratory disease should be offered the respiratory syncytial virus (RSV) vaccine, JCVI ...

INSM scraps Brinsupri for HS after phase IIb failure, with placebo outperforming treatment despite no safety issues.

The DPP1 inhibitor did not beat placebo in this trial, leaving branded Bimzelx and Cosentyx, as well as Humira and its ...

A new fund named in honour of a young Northland woman who died from a devastating lung disease at 24 will help support families affected by bronchiectasis. The Asthma and Respiratory Foundation NZ has ...

Insmed Inc. (NASDAQ:INSM) is one of the 10 Stocks Leaving the Market in the Dust Today. Insmed snapped a two-day losing streak on Monday, adding 5.52 percent to close at $153.32 apiece, as investors ...

If you have non-cystic fibrosis bronchiectasis, you’re likely an expert on the “lung side” of the disease — the stubborn mucus, the nagging cough, and the constant threat of a flare-up. But by causing ...

One woman's journey from an unexpected diagnosis to learning how to manage a chronic, progressive lung disease. When Lavonda was told she had bronchiectasis, she didn't know what the word meant. "I ...